This study evaluates Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis(PRECOMBAT trial).
This study is an extended one of PRECOMBAT trial.
Study Type
OBSERVATIONAL
Enrollment
600
Using sirolimus eluting stent
coronary artery bypass graft
Chonnam National University Hospital
Gwangju, South Korea
Seoul National University Bundang hospital
Seongnam, South Korea
Asan Medical Center
Seoul, South Korea
Korea University Anam Hospital
Seoul, South Korea
Composite outcome
The composite of death, myocardial infarction, and revascularization. Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, and revascularization
Time frame: 10 year
All-cause mortality
Time frame: 10 year
Cardiac death
Time frame: 10 year
Myocardial infarction
Time frame: 10 year
Cerebrovascular accident
Time frame: 10 year
Target vessel revascularization
Time frame: 10 year
Target lesion revascularization
Time frame: 10 year
Stent thrombosis
Time frame: 10 year
Binary restenosis in both in-stent and in-segment
Time frame: 10 year
Graft reocclusion rate
Time frame: 10 year
Graft patency rate
Time frame: 10 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Korea University Guro Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Ajou University Hospital
Suwon, South Korea
Ulsan University Hospital
Ulsan, South Korea